Morpholine → (1S,2R)-2-(4-chlorophenyl)-1'-(3-(morpholine-4-carbonyl)benzyl)spiro[cyclopropane-1,3'-indolin]-2'-one
Reaction equation
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[Cl:7][C:8]1[CH:13]=[CH:12][C:11]([C@@H:14]2[C@:16]3([C:24]4[C:19](=[CH:20][CH:21]=[CH:22][CH:23]=4)[N:18]([CH2:25][C:26]4[CH:27]=[C:28]([CH:32]=[CH:33][CH:34]=4)[C:29](O)=[O:30])[C:17]3=[O:35])[CH2:15]2)=[CH:10][CH:9]=1>>[Cl:7][C:8]1[CH:13]=[CH:12][C:11]([C@@H:14]2[C@:16]3([C:24]4[C:19](=[CH:20][CH:21]=[CH:22][CH:23]=4)[N:18]([CH2:25][C:26]4[CH:34]=[CH:33][CH:32]=[C:28]([C:29]([N:1]5[CH2:6][CH2:5][O:4][CH2:3][CH2:2]5)=[O:30])[CH:27]=4)[C:17]3=[O:35])[CH2:15]2)=[CH:10][CH:9]=1Participants
3
Procedure
The title compound was prepared in analogy to Example 60 starting from morpholine, (3-bromomethyl)-benzoate (commercially available) and (1R,2S) and (1S,2R)-3-((2-(4-chlorophenyl)-2′-oxospiro[cyclopropane-1,3′-indoline]-1′-yl)methyl)benzoic acid prepared as in Scheme 1. LC/MS m/e calcd. for C28H25ClN2O3: 472, observed (M+H)+: 473.2 1H NMR (400 MHz, MeOD-d4) δppm 2.15-2.27 (m, 2 H) 3.18-3.36 (m, 1 H) 3.47 (br. s., 4 H) 3.70 (br. s., 4 H) 5.11 (s, 2 H) 6.08 (d, J=7.58 Hz, 1 H) 6.71 (t, J=7.58 Hz, 1 H) 6.88 (d, J=8.08 Hz, 1 H) 7.01-7.12 (m, 1 H) 7.17-7.26 (m, 2 H) 7.25-7.40 (m, 4 H) 7.43-7.56 (m, 2 H).
Sources & evidence
- ORD record
- ord-283ecbb28792493a9d794b98ce2399b7
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354443B2
Reaction notes
Loading…